Trade Analytics

Serum Institute of India

Go Back

Serum Institute of India

  • One of India's top biotechnology company
  • Company sells products in 140 countries worldwide
  • More than 1.3 billion doses produced and sold globally

Serum Institute of India Ltd is the world's largest vaccine manufacturer by number of doses produced and sold globally (more than 1.3 billion doses) which includes Polio vaccine as well as Diphtheria, Tetanus, Pertussis, Hib, BCG, r-Hepatitis B, Measles, Mumps and Rubella vaccines. It is estimated that about 65 per cent of the children in the world receive at least one vaccine manufactured by Serum Institute. Vaccines manufactured by the Serum Institute are accredited by the World Health Organization, Geneva and are being used in around 140 countries across the globe in their national immunisation programs, saving millions of lives throughout the world.

Serum Institute of India is ranked as India's No. 1 biotechnology company, manufacturing highly specialised lifesaving biologicals like vaccines using cutting edge genetic and cell based technologies, antisera and other medical specialties.

Serum Institute of India was founded in 1966 by Dr. Cyrus Poonawalla with the aim of manufacturing life-saving immuno-biologicals, which were in shortage in the country and imported at high prices. Thereafter, several life-saving biologicals were manufactured at prices affordable to the common man and in abundance, with the result that the country was made self-sufficient for Tetanus Anti-toxin and Anti-snake Venom serum, followed by DTP (Diphtheria, Tetanus and Pertussis) group of Vaccines and then later on MMR (Measles, Mumps and Rubella) group of vaccines.

Serum Institute of India has set up the Serum Bio Pharma Park, India's first biotech special economic zone (SEZ). The Park is adjoining Serum Institute's existing manufacturing unit and is a sector-specific SEZ meant for biotechnology and pharmaceutical products.

Source: http://www.seruminstitute.com/

Serum Institute of India: Gaining Global Ground

  2015

Dr Cyrus Poonawalla, Chairman and Managing Director, conferred with Honorary D Litt (Honoris Causa)

  2013

Launched Oral Polio Vaccine (OPV)

  2012

Acquired Bilthoven Biologicals from the Netherlands Government

  2010

Launches H1N1 influenza vaccine (live) – Nasovac, liquid pentavalent vaccine in pre-filled syringes – Pentavac PFS, IPV Poliovac PFS, and r-EPO – Repoitin in pre-filled syringes

  2008

Launches combi-pack of pentavalent vaccine – Pentavac and quadravalent vaccine, Quadrovax. It is recognized as India's No. 1 Bio-tech company for the 3rd consecutive year

  2005

Launches indigenously developed DTP-HB combination vaccine – SII Q-VAC

  2001

Launches indigenously manufactured Hepatitis-B vaccine (rDNA) – GeneVac-B

  1993

Launches India's first MMR Vaccine – Tresivac

Updated: October, 2015

Pharmaceuticals
India's pharmaceutical sector will touch US$ 45 billion by 2020.